229 related articles for article (PubMed ID: 17276525)
41. A non-peptide antagonist unusually selective for the human form of the bradykinin B2 receptor.
Marceau F; Fortin JP; Morissette G; Dziadulewicz EK
Int Immunopharmacol; 2003 Oct; 3(10-11):1529-36. PubMed ID: 12946450
[TBL] [Abstract][Full Text] [Related]
42. Pharmacological characterisation of the first non-peptide bradykinin B2 receptor agonist FR 190997: an in vitro study on human, rabbit and pig vascular B2 receptors.
Rizzi A; Rizzi C; Amadesi S; Calo' G; Varani K; Inamura N; Regoli D
Naunyn Schmiedebergs Arch Pharmacol; 1999 Oct; 360(4):361-7. PubMed ID: 10551272
[TBL] [Abstract][Full Text] [Related]
43. Role of bradykinin B2 receptors in the modulation of the peristaltic reflex of the guinea pig isolated ileum.
Chan SK; Rudd JA
Eur J Pharmacol; 2006 Jun; 539(1-2):108-15. PubMed ID: 16650846
[TBL] [Abstract][Full Text] [Related]
44. Plasma extravasation mediated by lipopolysaccharide-induction of kinin B1 receptors in rat tissues.
Wille PR; Vitor R; Gabilan NH; Nicolau M
Mediators Inflamm; 2001 Jun; 10(3):163-7. PubMed ID: 11545253
[TBL] [Abstract][Full Text] [Related]
45. In various tumour cell lines the peptide bradykinin B(2) receptor antagonist, Hoe 140 (Icatibant), may act as mitogenic agonist.
Drube S; Liebmann C
Br J Pharmacol; 2000 Dec; 131(8):1553-60. PubMed ID: 11139431
[TBL] [Abstract][Full Text] [Related]
46. Interleukin-1beta enhances the action of bradykinin in rat myenteric neurons through up-regulation of glial B1 receptor expression.
Murakami M; Ohta T; Ito S
Neuroscience; 2008 Jan; 151(1):222-31. PubMed ID: 18053651
[TBL] [Abstract][Full Text] [Related]
47. Purification, structural characterization, and myotropic activity of a peptide related to des-Arg(9)-bradykinin from an elasmobranch fish, the little skate, Leucoraja erinacea.
Anderson WG; Leprince J; Conlon JM
Peptides; 2008 Aug; 29(8):1280-6. PubMed ID: 18502540
[TBL] [Abstract][Full Text] [Related]
48. New bradykinin B(2) receptor antagonists - influence of C-terminal segment modifications on their pharmacological properties.
Sleszyńska M; Kwiatkowska A; Sobolewski D; Wierzba TH; Katarzyńska J; Zabrocki J; Borovickova L; Slaninová J; Prahl A
Acta Biochim Pol; 2009; 56(4):641-8. PubMed ID: 19997652
[TBL] [Abstract][Full Text] [Related]
49. Bradykinin B2 type receptor activation regulates fluid and electrolyte transport in the rabbit kidney.
Hébert RL; Regoli D; Xiong H; Breyer MD; Plante GE
Peptides; 2005 Aug; 26(8):1308-16. PubMed ID: 16042972
[TBL] [Abstract][Full Text] [Related]
50. Pharmacological characterization of bradykinin receptors coupled to phosphoinositide turnover in SV40-immortalized human trabecular meshwork cells.
Sharif NA; Xu SX
Exp Eye Res; 1996 Dec; 63(6):631-7. PubMed ID: 9068370
[TBL] [Abstract][Full Text] [Related]
51. International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences.
Leeb-Lundberg LM; Marceau F; Müller-Esterl W; Pettibone DJ; Zuraw BL
Pharmacol Rev; 2005 Mar; 57(1):27-77. PubMed ID: 15734727
[TBL] [Abstract][Full Text] [Related]
52. Characterization of bradykinin receptors in canine cultured corneal epithelial cells: pharmacological and functional studies.
Huang SC; Hsiao LD; Chien CS; Wang CC; Chiu CT; Tsai RJ; Yang CM
J Biomed Sci; 2002; 9(3):213-22. PubMed ID: 12065896
[TBL] [Abstract][Full Text] [Related]
53. A fluorescent version of the bradykinin B2 receptor antagonist B-9430: pharmacological characterization and use in live cell imaging.
Bawolak MT; Gera L; Bouthillier J; Stewart JM; Adam A; Marceau F
Peptides; 2008 Sep; 29(9):1626-30. PubMed ID: 18565624
[TBL] [Abstract][Full Text] [Related]
54. Fluorescent ligands of the bradykinin B1 receptors: pharmacologic characterization and application to the study of agonist-induced receptor translocation and cell surface receptor expression.
Bawolak MT; Gera L; Morissette G; Bouthillier J; Stewart JM; Gobeil LA; Lodge R; Adam A; Marceau F
J Pharmacol Exp Ther; 2009 Apr; 329(1):159-68. PubMed ID: 19136639
[TBL] [Abstract][Full Text] [Related]
55. Differences in electromechanical coupling between bradykinin and the nonpeptide kinin B2 receptor agonist, FR 190997, in the circular muscle of guinea-pig colon.
Santicioli P; Catalioto RM; Meini S; Maggi CA
Naunyn Schmiedebergs Arch Pharmacol; 2001 Feb; 363(2):175-81. PubMed ID: 11218070
[TBL] [Abstract][Full Text] [Related]
56. Bradykinin-induced IL-6 expression through bradykinin B2 receptor, phospholipase C, protein kinase Cdelta and NF-kappaB pathway in human synovial fibroblasts.
Lee CH; Shieh DC; Tzeng CY; Chen CP; Wang SP; Chiu YC; Huang CY; Hsu CJ; Fong YC; Tang CH
Mol Immunol; 2008 Aug; 45(14):3693-702. PubMed ID: 18621420
[TBL] [Abstract][Full Text] [Related]
57. In vitro and in vivo effects of kinin B(1) and B(2) receptor agonists and antagonists in inbred control and cardiomyopathic hamsters.
Hallé S; Gobeil F; Ouellette J; Lambert C; Regoli D
Br J Pharmacol; 2000 Apr; 129(8):1641-8. PubMed ID: 10780969
[TBL] [Abstract][Full Text] [Related]
58. Design of fluorescent bradykinin analogs: application to imaging of B2 receptor-mediated agonist endocytosis and trafficking and angiotensin-converting enzyme.
Gera L; Bawolak MT; Roy C; Lodge R; Marceau F
J Pharmacol Exp Ther; 2011 Apr; 337(1):33-41. PubMed ID: 21205920
[TBL] [Abstract][Full Text] [Related]
59. A plant Kunitz-type inhibitor mimics bradykinin-induced cytosolic calcium increase and intestinal smooth muscle contraction.
Andrade SS; Smaili SS; Monteforte PT; Miranda A; Kouyoumdjian M; Sampaio MU; Lopes GS; Oliva ML
Biol Chem; 2012 Sep; 393(9):943-57. PubMed ID: 22944694
[TBL] [Abstract][Full Text] [Related]
60. Further pharmacological evaluation of a novel synthetic peptide bradykinin B2 receptor agonist.
Savard M; Labonté J; Dubuc C; Neugebauer W; D'Orléans-Juste P; Gobeil F
Biol Chem; 2013 Mar; 394(3):353-60. PubMed ID: 23362191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
